2-Fucosyllactose
CAS No. 41263-94-9
2-Fucosyllactose( 2'-FL )
Catalog No. M25032 CAS No. 41263-94-9
2'-Fucosyllactose (2'-FL) is an oligosaccharide that could be derived from human milk.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 87 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name2-Fucosyllactose
-
NoteResearch use only, not for human use.
-
Brief Description2'-Fucosyllactose (2'-FL) is an oligosaccharide that could be derived from human milk.
-
Description2'-Fucosyllactose (2'-FL) is an oligosaccharide that could be derived from human milk. 2'-Fucosyllactose regulates the expression of CD14, alleviates colitis and regulates the gut microbiome. 2'-Fucosyllactose stimulates T cells to increase IFN-γ production and decreases IL-6, IL-17, and TNF-α production of cytokines.
-
In Vitro2'-Fucosyllactose (2'-FL; 0-12 mg/mL; 48 h) suppress cell-associated CD14 expression and to attenuate LPS (100 μg/mL) stimulated IL-8 secretion in T84 cells.2'-Fucosyllactose (2 mg/mL; 48 h; T84 and HCT8 cells) ameliorates inflammation induced by bacterial invasion. 2'-Fucosyllactose inhibits ETEC invasion and attenuated the consequent IL-8 secretion.2'-Fucosyllactose (2 mg/mL; 48 h; T84 and HCT8 cells) induces macrophage migration inhibitory factor signal pathways that suppress inflammation. Western Blot Analysis Cell Line:T84 cells Concentration:0, 2, and 4 mg/mL Incubation Time:48 hours Result:Suppressed CD14 mRNA and reduced cell-associated CD14 protein expression.Western Blot Analysis Cell Line:T84 and HCT8 cells T84 and HCT8 cells Concentration:2 mg/mL Incubation Time:48 hours Result:Suppressed CD14 mRNA and reduced cell-associated CD14 protein expression.Inhibited CD14 and NF-κB induction.Induced iκB and SOCS2 expression and STAT3 phosphorylation.
-
In Vivo2'-Fucosyllactose (2'-FL; 100 mg (200 μL); i.g.; daily, for 4 d; C57BL/6 mice with AIEC infection) inhibits AIEC infection and inflammation in vivo. Animal Model:C57BL/6 mice (8 weeks) with AIEC (uropathogenic E. coli, and adherent-invasive E. coli) infection Dosage:100 mg (200 μL)Administration:Oral gavage; daily, for 4 days Result:Had colons lengths were closer to normal.Inhibited the colonisation of the colonic mucosa by O83-positive bacteria.Decreased CD14 expression, CD14 mRNA levels, IL-6, IL-17 and TNF-α levels in colonic.
-
Synonyms2'-FL
-
PathwayApoptosis
-
TargetTNF
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number41263-94-9
-
Formula Weight488.44
-
Molecular FormulaC18H32O15
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 50 mg/mL (102.37 mM)
-
SMILESO=C[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO)O)O)O[C@H]2[C@H]([C@@H]([C@@H]([C@@H](O2)C)O)O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. He Y, et, al. The human milk oligosaccharide 2'-fucosyllactose modulates CD14 expression in human enterocytes, thereby attenuating LPS-induced inflammation. Gut. 2016 Jan;65(1):33-46.
2. Eiwegger T, et, al. Human milk--derived oligosaccharides and plant-derived oligosaccharides stimulate cytokine production of cord blood T-cells in vitro. Pediatr Res. 2004 Oct;56(4):536-40.
molnova catalog
related products
-
Tulisokibart
Tulisokibart (PRA023) is a humanized anti-TNFSF15 monoclonal antibody used to study colon cancer.
-
Utomilumab
Utomilumab (PF 05082566) is a humanized IgG2 antibody that targets the T-cell co-stimulatory receptor 4-1BB/CD137 and acts as a 4-1BB/CD137 agonist.
-
UCB-5307
UCB-5307 is a small molecule compound that inhibits TNFR1 signal transduction and downstream function in vitro.
Cart
sales@molnova.com